查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855962

2025年量子增強預測基因組學全球市場報告

Quantum-Enhanced Predictive Genomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，量子增強預測基因組學市場呈指數級成長，從2024年的14.5億美元成長到2025年的19.5億美元，複合年成長率達34.1%。這段歷史性成長時期主要受以下因素驅動：精準醫療需求不斷成長、基因組數據日益複雜、量子運算投資不斷增加、疾病預測應用範圍不斷擴大以及科技與醫療保健產業合作日益密切。

預計未來幾年，量子增強預測基因組學市場將呈指數級成長，到2029年市場規模將達到62.6億美元，年複合成長率（CAGR）高達33.8%。預測期內的成長主要受以下因素驅動：個人化醫療的廣泛應用、人工智慧與量子基因組學的日益融合、對疾病早期檢測的日益重視、政府和私人研發投入的增加以及先進基因組資料集的廣泛應用。這段時期的關鍵趨勢包括：量子機器學習模型的開發、基因組資料加密和安全的創新、多體學與量子分析的融合、雲端基礎的量子基因組學平台的開發以及量子技術公司與生物技術公司之間的合作。

量子增強預測基因組學利用量子計算分析複雜的基因組數據，以便更快、更準確地預測疾病風險、治療反應和其他健康結果。這種方法能夠識別大型基因資料集中的模式，而這些模式往往被傳統方法所忽略，從而支持生物標記的發現和個人化醫療。

量子增強預測基因體學的關鍵技術包括量子計算、量子機器學習、量子密碼學及相關工具。量子運算是一種先進的運算平台，旨在快速分析和解讀複雜的基因組數據。這些解決方案可部署在雲端基礎或本地環境中，並被製藥和生物技術公司、研究機構、醫療保健提供者以及其他從事基因組學和精準醫療的組織廣泛應用。

美國在2025年春季突然提高關稅，由此引發的貿易摩擦對醫療保健產業造成了嚴重衝擊，尤其對關鍵醫療設備、診斷試劑和藥品的供應造成了嚴重影響。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的緊張，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為了應對這項挑戰，醫療產業正在積極調整籌資策略，盡可能地促進本地生產，並呼籲對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供量子增強預測基因組學市場統計數據，例如全球市場規模、區域佔有率、佔據量子增強預測基因組學市場佔有率的競爭對手、詳細的量子增強預測基因組學市場細分、市場趨勢以及量子增強預測基因組學行業的商業機會。本量子增強預測基因組學市場研究報告提供您所需的一切資訊，並對該行業的現狀和未來發展趨勢進行詳細分析。

預計對個人化醫療日益成長的需求將推動量子增強型預測基因組學市場的成長。個人化醫療是指根據個人獨特的基因、生物學和臨床特徵，量身訂做醫療、治療和預防策略。對個人化醫療需求的成長主要源自於其提高治療效果的能力。針對患者基因組成所製定的治療方法通常能帶來更好的療效和更少的副作用。量子增強型預測基因組學在其中發揮關鍵作用，它能夠對複雜的基因組數據進行超快速分析，使臨床醫生能夠制定高度精準的個人化治療方案。例如，英國國家醫療服務體系（NHS）英格蘭分部報告稱，2024年透過NHS基因組醫學服務為患者提供了超過81萬次個人化基因組檢測，比上一年成長了8%，這反映了對基因組主導醫療服務日益成長的需求。因此，對個人化醫療的需求預計將推動量子增強型預測基因組學市場的成長。

量子增強預測基因組學市場的主要企業正致力於高通量基因組數據處理等創新技術，以加速基因突變的識別，提高個人化醫療的預測準確性，並實現對複雜基因組資料集更快、更準確的分析。高通量基因組資料處理是指利用先進的計算方法對基因組序列進行快速、大規模的分析。例如，2025年6月，總部位於德國的Norma集團（專注於工程化和標準化偶聯及流體處理技術的公司）與首爾大學盆唐醫院（SNUBH）合作，將量子演算法應用於大規模基因組分析。此次合作旨在透過量子組合最佳化加速基因突變的檢測，並提高基因組數據處理的速度和準確性，使其優於傳統計算方法。其主要應用包括精準診斷、個人化治療方案製定以及癌症和神經系統疾病的遺傳風險評估。

2025年8月，英國軟體公司Quantinuum將與惠康桑格研究所合作，推動量子運算在基因組學領域的應用。此次合作是桑格研究所「惠康生物量子飛躍」（Q4Bio）挑戰計畫的一部分，該計畫是一項旨在支持基於量子技術的基因組分析研究的全球性計劃。惠康桑格研究所致力於開發量子增強型預測基因組學解決方案。

量子增強型預測基因組學市場由提供臨床決策支援服務、腫瘤特異性預測基因組學服務和多組體學整合服務等服務的營業單位所獲得的收入組成。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。量子增強型預測基因組學市場包括量子驅動的表觀遺傳預測工具、量子整合的個人化預防醫學工具和量子增強型合成生物學設計平台的銷售。該市場的價值為“出廠價”，即產品製造商或創建者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品創建者銷售的任何相關服務的價值。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球量子增強預測基因體學：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球量子增強預測基因組學市場：成長率分析
  • 全球量子增強預測基因組學市場表現：規模與成長，2019-2024年
  • 全球量子增強基因組學市場預測：規模與成長，2024-2029年，2034年預測
  • 全球量子增強預測基因體學：潛在市場規模 (TAM)

第6章 市場細分

  • 全球量子增強基因體學市場：依技術、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 量子計算
  • 量子機器學習
  • 量子密碼學
  • 其他技術
  • 全球量子增強基因體學市場依部署模式分類，實際數據及預測（2019-2024年、2024-2029年預測、2034年預測）。
  • 本地部署
  • 雲端基礎的
  • 全球量子增強基因體學市場：依應用領域分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 疾病風險評估
  • 藥物發現
  • 個人化醫療
  • 基因組數據分析
  • 其他用途
  • 全球量子增強基因體學市場：依最終用戶分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 製藥和生物技術公司
  • 研究所
  • 醫療保健提供者
  • 其他最終用戶
  • 全球量子增強基因體學市場：以量子計算、類型、實際值和預測值（2019-2024年、2024-2029年預測值、2034年預測值）進行細分
  • 基於閘的量子計算
  • 量子退火
  • 拓樸量子計算
  • 光子量子運算
  • 全球量子增強預測基因組學市場：按量子機器學習、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 監督式學習
  • 無監督學習
  • 強化學習
  • 深度學習
  • 全球量子增強基因組學市場：按量子密碼學、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 量子金鑰分發
  • 量子隨機數生成
  • 量子安全通訊
  • 後量子密碼學
  • 全球量子增強基因體學市場：依技術、類型、實際值及預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 量子感測器
  • 量子模擬
  • 量子網路
  • 混合量子-經典系統

第7章 區域和國家分析

  • 全球量子增強基因體學市場：依地區分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 全球量子增強基因組學市場：按國家/地區分類，實際值和預測值，2019-2024 年、2024-2029 年預測值、2034 年預測值

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 量子增強預測基因體學市場：競爭格局
  • 量子增強預測基因組學市場：公司概況
    • Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
    • Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • F. Hoffmann-La Roche AG
  • Accenture plc
  • IBM Corporation
  • Pfizer Inc.
  • Bayer AG
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Honeywell International Inc.
  • Fujitsu Limited
  • Eviden
  • Xanadu Quantum Technologies Inc.
  • Pasqal SA
  • Rigetti Computing Inc.
  • IonQ Inc.
  • D-Wave Systems Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年量子增強預測基因體學市場：提供新機會的國家
  • 2029年量子增強預測基因體學市場：提供新機會的細分市場
  • 2029年量子增強預測基因體學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38614

Quantum-enhanced predictive genomics involves using quantum computing to analyze complex genomic data, enabling faster and more precise predictions of disease risk, treatment response, and other health outcomes. This approach identifies patterns in large-scale genetic datasets that conventional methods may overlook, supporting biomarker discovery and personalized medicine.

The primary technologies in quantum-enhanced predictive genomics include quantum computing, quantum machine learning, quantum cryptography, and related tools. Quantum computing consists of advanced computational platforms designed for rapid analysis and interpretation of complex genomic datasets. These solutions can be deployed in cloud-based or on-premises environments and are used by pharmaceutical and biotechnology companies, research institutes, healthcare providers, and other organizations engaged in genomics and precision medicine.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The quantum-enhanced predictive genomics market research report is one of a series of new reports from The Business Research Company that provides quantum-enhanced predictive genomics market statistics, including the quantum-enhanced predictive genomics industry global market size, regional shares, competitors with the quantum-enhanced predictive genomics market share, detailed quantum-enhanced predictive genomics market segments, market trends, and opportunities, and any further data you may need to thrive in the quantum-enhanced predictive genomics industry. This quantum-enhanced predictive genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The quantum-enhanced predictive genomics market size has grown exponentially in recent years. It will grow from $1.45 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 34.1%. The growth during the historic period is driven by rising demand for precision medicine, increasing complexity of genomic data, growing investments in quantum computing, expanding applications in disease prediction, and stronger collaborations between technology and healthcare sectors.

The quantum-enhanced predictive genomics market size is expected to see exponential growth in the next few years. It will grow to $6.26 billion in 2029 at a compound annual growth rate (CAGR) of 33.8%. The projected growth in the forecast period is supported by wider adoption of personalized healthcare, greater integration of AI with quantum genomics, increased focus on early disease detection, rising government and private R&D funding, and broader availability of advanced genomic datasets. Key trends in this period include advancements in quantum machine learning models, innovations in genomic data encryption and security, integration of multi-omics with quantum analytics, development of cloud-based quantum genomics platforms, and collaborations between quantum technology firms and biotechnology companies.

The increasing demand for personalized medicine is anticipated to drive the growth of the quantum-enhanced predictive genomics market. Personalized medicine involves tailoring medical care, treatments, and prevention strategies based on an individual's unique genetic, biological, and clinical profile. The rise in demand for personalized medicine is largely due to its ability to improve treatment effectiveness. Therapies that are tailored to a patient's genetic makeup often lead to better outcomes and fewer side effects. Quantum-enhanced predictive genomics plays a key role in this by enabling ultra-fast analysis of complex genomic data, which allows clinicians to develop highly precise and individualized treatment plans. For example, in 2024, NHS England reported that over 810,000 personalized genomic tests were delivered to patients through the NHS genomic medicine service, an 8% increase from the previous year, reflecting the growing demand for genomic-led care. As a result, the demand for personalized medicine is expected to fuel the growth of the quantum-enhanced predictive genomics market.

Leading companies in the quantum-enhanced predictive genomics market are focusing on innovations such as high-throughput genomic data processing to speed up the identification of genetic variations, enhance predictive accuracy in personalized medicine, and enable faster, more precise analysis of complex genomic datasets. High-throughput genomic data processing refers to the rapid, large-scale analysis of genomic sequences using advanced computational methods. For instance, in June 2025, Norma Group, a Germany-based company specializing in engineered and standardized joining and fluid-handling technology, partnered with Seoul National University Bundang Hospital (SNUBH) to apply quantum algorithms to large-scale genomic analysis. The collaboration aims to accelerate the detection of genetic mutations through quantum-enhanced combinatorial optimization, enhancing both the speed and accuracy of genomic data processing beyond classical computing methods. Key applications include precision diagnostics, personalized treatment planning, and genetic risk assessment for diseases such as cancer and neurological disorders.

In August 2025, Quantinuum, a UK-based software company, teamed up with the Wellcome Sanger Institute to advance quantum computing applications in genomics. This partnership is part of the Sanger Institute's Wellcome Leap Quantum for Bio (Q4Bio) challenge, a global initiative aimed at supporting research in quantum-based genomic analysis. The Wellcome Sanger Institute is focused on developing quantum-enhanced predictive genomics solutions.

Major players in the quantum-enhanced predictive genomics market are Google LLC, Microsoft Corporation, Alibaba Group Holding Limited, Amazon Web Services Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Accenture plc, IBM Corporation, Pfizer Inc., Bayer AG, AstraZeneca plc, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, Eviden, Xanadu Quantum Technologies Inc., Pasqal SA, Rigetti Computing Inc., IonQ Inc., D-Wave Systems Inc.

North America was the largest region in the quantum-enhanced predictive genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quantum-enhanced predictive genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the quantum-enhanced predictive genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quantum-enhanced predictive genomics market consists of revenues earned by entities by providing services such as clinical decision support services, oncology-focused predictive genomics services, and multi-omics integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantum-enhanced predictive genomics market includes sales of quantum-powered epigenetic predictive tools, quantum-integrated personalized preventive health tools, and quantum-enhanced synthetic biology design platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quantum-Enhanced Predictive Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quantum-enhanced predictive genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quantum-enhanced predictive genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quantum-enhanced predictive genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Quantum Computing; Quantum Machine Learning; Quantum Cryptography; Other Technologies
  • 2) By Deployment Mode: On-Premises; Cloud-Based
  • 3) By Application: Disease Risk Assessment; Drug Discovery; Personalized Medicine; Genomic Data Analysis; Other Applications
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Healthcare Providers; Other End-Users
  • Subsegments:
  • 1) By Quantum Computing: Gate Based Quantum Computing; Quantum Annealing; Topological Quantum Computing; Photonic Quantum Computing
  • 2) By Quantum Machine Learning: Supervised Learning; Unsupervised Learning; Reinforcement Learning; Deep Learning
  • 3) By Quantum Cryptography: Quantum Key Distribution; Quantum Random Number Generation; Quantum Secure Communication; Post Quantum Cryptography
  • 4) By Other Technologies: Quantum Sensors; Quantum Simulation; Quantum Networking; Hybrid Quantum Classical Systems
  • Companies Mentioned: Google LLC; Microsoft Corporation; Alibaba Group Holding Limited; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Accenture plc; IBM Corporation; Pfizer Inc.; Bayer AG; AstraZeneca plc; GlaxoSmithKline plc; Honeywell International Inc.; Fujitsu Limited; Eviden; Xanadu Quantum Technologies Inc.; Pasqal SA; Rigetti Computing Inc.; IonQ Inc.; D-Wave Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Quantum-Enhanced Predictive Genomics Market Characteristics

3. Quantum-Enhanced Predictive Genomics Market Trends And Strategies

4. Quantum-Enhanced Predictive Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Quantum-Enhanced Predictive Genomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Quantum-Enhanced Predictive Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Quantum-Enhanced Predictive Genomics Market Growth Rate Analysis
  • 5.4. Global Quantum-Enhanced Predictive Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Quantum-Enhanced Predictive Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Quantum-Enhanced Predictive Genomics Total Addressable Market (TAM)

6. Quantum-Enhanced Predictive Genomics Market Segmentation

  • 6.1. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantum Computing
  • Quantum Machine Learning
  • Quantum Cryptography
  • Other Technologies
  • 6.2. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Risk Assessment
  • Drug Discovery
  • Personalized Medicine
  • Genomic Data Analysis
  • Other Applications
  • 6.4. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Research Institutes
  • Healthcare Providers
  • Other End-Users
  • 6.5. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Computing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gate Based Quantum Computing
  • Quantum Annealing
  • Topological Quantum Computing
  • Photonic Quantum Computing
  • 6.6. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Machine Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Supervised Learning
  • Unsupervised Learning
  • Reinforcement Learning
  • Deep Learning
  • 6.7. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Cryptography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantum Key Distribution
  • Quantum Random Number Generation
  • Quantum Secure Communication
  • Post Quantum Cryptograp
  • 6.8. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantum Sensors
  • Quantum Simulation
  • Quantum Networking
  • Hybrid Quantum Classical Systems

7. Quantum-Enhanced Predictive Genomics Market Regional And Country Analysis

  • 7.1. Global Quantum-Enhanced Predictive Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Quantum-Enhanced Predictive Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quantum-Enhanced Predictive Genomics Market

  • 8.1. Asia-Pacific Quantum-Enhanced Predictive Genomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quantum-Enhanced Predictive Genomics Market

  • 9.1. China Quantum-Enhanced Predictive Genomics Market Overview
  • 9.2. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quantum-Enhanced Predictive Genomics Market

  • 10.1. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quantum-Enhanced Predictive Genomics Market

  • 11.1. Japan Quantum-Enhanced Predictive Genomics Market Overview
  • 11.2. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quantum-Enhanced Predictive Genomics Market

  • 12.1. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quantum-Enhanced Predictive Genomics Market

  • 13.1. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quantum-Enhanced Predictive Genomics Market

  • 14.1. South Korea Quantum-Enhanced Predictive Genomics Market Overview
  • 14.2. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quantum-Enhanced Predictive Genomics Market

  • 15.1. Western Europe Quantum-Enhanced Predictive Genomics Market Overview
  • 15.2. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quantum-Enhanced Predictive Genomics Market

  • 16.1. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quantum-Enhanced Predictive Genomics Market

  • 17.1. Germany Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quantum-Enhanced Predictive Genomics Market

  • 18.1. France Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quantum-Enhanced Predictive Genomics Market

  • 19.1. Italy Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quantum-Enhanced Predictive Genomics Market

  • 20.1. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quantum-Enhanced Predictive Genomics Market

  • 21.1. Eastern Europe Quantum-Enhanced Predictive Genomics Market Overview
  • 21.2. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quantum-Enhanced Predictive Genomics Market

  • 22.1. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quantum-Enhanced Predictive Genomics Market

  • 23.1. North America Quantum-Enhanced Predictive Genomics Market Overview
  • 23.2. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quantum-Enhanced Predictive Genomics Market

  • 24.1. USA Quantum-Enhanced Predictive Genomics Market Overview
  • 24.2. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quantum-Enhanced Predictive Genomics Market

  • 25.1. Canada Quantum-Enhanced Predictive Genomics Market Overview
  • 25.2. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quantum-Enhanced Predictive Genomics Market

  • 26.1. South America Quantum-Enhanced Predictive Genomics Market Overview
  • 26.2. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quantum-Enhanced Predictive Genomics Market

  • 27.1. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quantum-Enhanced Predictive Genomics Market

  • 28.1. Middle East Quantum-Enhanced Predictive Genomics Market Overview
  • 28.2. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quantum-Enhanced Predictive Genomics Market

  • 29.1. Africa Quantum-Enhanced Predictive Genomics Market Overview
  • 29.2. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quantum-Enhanced Predictive Genomics Market Competitive Landscape And Company Profiles

  • 30.1. Quantum-Enhanced Predictive Genomics Market Competitive Landscape
  • 30.2. Quantum-Enhanced Predictive Genomics Market Company Profiles
    • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Quantum-Enhanced Predictive Genomics Market Other Major And Innovative Companies

  • 31.1. F. Hoffmann-La Roche AG
  • 31.2. Accenture plc
  • 31.3. IBM Corporation
  • 31.4. Pfizer Inc.
  • 31.5. Bayer AG
  • 31.6. AstraZeneca plc
  • 31.7. GlaxoSmithKline plc
  • 31.8. Honeywell International Inc.
  • 31.9. Fujitsu Limited
  • 31.10. Eviden
  • 31.11. Xanadu Quantum Technologies Inc.
  • 31.12. Pasqal SA
  • 31.13. Rigetti Computing Inc.
  • 31.14. IonQ Inc.
  • 31.15. D-Wave Systems Inc.

32. Global Quantum-Enhanced Predictive Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quantum-Enhanced Predictive Genomics Market

34. Recent Developments In The Quantum-Enhanced Predictive Genomics Market

35. Quantum-Enhanced Predictive Genomics Market High Potential Countries, Segments and Strategies

  • 35.1 Quantum-Enhanced Predictive Genomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Quantum-Enhanced Predictive Genomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Quantum-Enhanced Predictive Genomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer